Navigation Links
CEO Addresses Fort Worth Business Leaders About Developing Pandemic and Business Continuity Plans
Date:5/16/2008

o Sell For (Selling Power). In previous years, Roche has been named as a Top Company for Older Workers (AARP) and one of the Best Companies to Work For in America (Fortune). For additional information about the U.S. pharmaceuticals business, visit our websites: http://www.rocheusa.com or http://www.roche.us.

All trademarks used or mentioned in this release are protected by law.


'/>"/>
SOURCE Hoffmann-La Roche Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Publication Addresses Misconceptions About Emergency Contraception
2. MIT researcher addresses biomedical engineering challenges
3. VaxGen Addresses MPM Claims in Letter to Stockholders
4. Free White Paper Addresses Challenges of New FDA Regulations Awaiting Combo Product Manufacturers
5. Abingworth Appoints David Mayer as Partner
6. Virgin Atlantic Selects Rolls-Royce Engines to Power Its 787 Fleet in a Deal Worth $2.6BN
7. Evotec Extends Ongoing Collaboration With CHDI Worth up to US$ 37 Million
8. ProMetic provides business update - Over $35 million worth of business secured in January
9. Vermillion Announces First Quarter 2008 Financial Results and Business Progress
10. ThromboGenics N.V. - Business Update
11. MedApps Selected as Dell-NFIB 2008 Business Excellence Award Finalist

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., MANILA, Philippines, Dec. 2 S...st growing green energy companies on the planet. T...True Green Planet,s President and Recycling Specia... business for over 25 years, stated that Spectrum ... setting the stage for spectacular earnings becaus...
(Date:12/2/2009)... , NEW YORK, Dec. 2 ...s, policy makers, and funders today convened to ex...funding strategies at the inaugural Partnering fo...gton-based center of the Milken Institute, convene...r collaborations needed to turn a scientific disco...
(Date:12/2/2009)... , LIBREVILLE, Gabon, December 2 /PRNewswi...rica: Everyone,s Problem and Heritage" , ...sity, 2-3 June 2010 the,Gabonese Republic is hosti...n) on the issue of safeguarding biological resourc...overnment and state leaders, ministers,scientific...
(Date:12/2/2009)... , SINGAPORE, Dec. 2 S*BI...s novel oral JAK2 inhibitor, SB1518, at The Americ...xposition in New Orleans. ,, Data will be prese...-escalation trial of SB1518 detailing its safety, ...PK/PD) profile in dose levels ranging from 100 to ...
Breaking Biology Technology:Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5
... to Bioniche,s growing line of injectable ...., July 2 Bioniche Pharma, a leading,developer an...unced today,the acquisition of Baxter Healthcare C...NLON(R) (edrophonium chloride injection, USP) 10 m...loride, USP and atropine sulfate, USP) Injecti...
... therapies based on cells manufactured from bon...nding round, SALT LAKE CITY and HAMBURG, Germany,... the forefront of innovative cell therapies,for th...d the closing of a,$14.5MM Series A financing. The...oining the syndicate., "This financing represents...
...lization of Expanded Portfolio of Vascular ...ish Columbia, July 2 Neovasc Inc. (TSXV:,NVC), fo...ny developing and,marketing innovative specialty v...nd the expansion of its product portfolio, as the ...product development companies and the,closing of a...
Other Biology Technology:Bioniche Pharma Acquires Baxter's ENLON(R) and ENLON-PLUS(R) 2AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 2AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury 3Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 2Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 3Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 4
(Date:12/2/2009)..., Recalls of ground beef, peanut butter, and other...and concern about food safety. They also are quiet...quipment and fostering new food safety regulations...the current issue of Chemical & Engineering News ...ate Editor Jyllian Kemsley and Senior Corresponden...
(Date:12/2/2009)...HOBOKEN - A team comprised of undergraduate studen...d top honors in a national poster contest hosted b...ineering (ISPE). , The annual contest highlights...ld last month at the ISPE Annual Meeting in San Di...tion of a Posterior Criciate Ligament Tensioning D...
(Date:12/2/2009)...Young adults who are fit have a higher IQ and are ...r new study carried out at the Sahlgrenska Academy...lts were published today in the prestigious Proce... ). The study involved 1.2 million Swedish men doi... 1976. The research group analysed the results of ...
Breaking Biology News(10 mins):Young adults who exercise get higher IQ 2Krogers Family of Pharmacies Offer Customers Easy and Affordable Seasonal Flu Vaccinations 55141 1Krogers Family of Pharmacies Offer Customers Easy and Affordable Seasonal Flu Vaccinations 55141 2Ranbaxy Receives Final Approval to Manufacture and Market Glycopyrrolate Tablets 55137 1Ranbaxy Receives Final Approval to Manufacture and Market Glycopyrrolate Tablets 55137 2Obama Named the Most Powerful Person in Healthcare 55134 1Obama Named the Most Powerful Person in Healthcare 55134 2
..., It has a beautiful, but also an unpleasant side:...stones, but also causes the lime scale in washing ... a long time - or has it? Scientists at the Max Pl...whittling away at the established theory, which is...hers investigated the crystallization of calcium c...
...n the Neonatal and Infant Feeding Disorders Progra...mature infants and other newborns with severe swal...cording to a study appearing in the February issue... Nutrition , physicians at Nationwide Children,s w...feeding difficulties and airway concerns learn to ...
...ers at Harvard University have shown that small pl...ns and implanted under the skin can reprogram the ...esearch -- which ridded 90 percent of mice of an a... the rodents within 25 days -- represents the most...ne. , Harvard,s David J. Mooney and colleagues de...
Other Biology News:A crystal clear view of chalk formation 2A crystal clear view of chalk formation 3A crystal clear view of chalk formation 4Crib-side studies help struggling newborns go home without feeding tubes 2Crib-side studies help struggling newborns go home without feeding tubes 3Implants mimic infection to rally immune system against tumors 2
Mouse Anti-SALMONELLA HADAR Monoclonal Antibody, Unconjugated, Clone 37/252 from AbD Serotec
Mouse Anti-Human IFN-Gamma RC2 (CD118) Non-Neutralizing Monoclonal Antibody, Unconjugated, Clone MMHGR-2 from PBL InterferonSource
Secure-Seal™ hybridization chamber gasket, eight chambers, 9 mm diameter, 0.8 mm deep *set of 20* from Molecular Probes (Invitrogen)
Rat CINC-2 beta, Unconjugated from R&D Systems
Biology Products: